Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

MicroRNA-155 Expression Is Enhanced by T-cell Receptor Stimulation Strength and Correlates with Improved Tumor Control in Melanoma.

Martinez-Usatorre A, Sempere LF, Carmona SJ, Carretero-Iglesia L, Monnot G, Speiser DE, Rufer N, Donda A, Zehn D, Jandus C, Romero P.

Cancer Immunol Res. 2019 Jun;7(6):1013-1024. doi: 10.1158/2326-6066.CIR-18-0504. Epub 2019 May 1.

PMID:
31043416
2.

TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.

Allard M, Couturaud B, Carretero-Iglesia L, Duong MN, Schmidt J, Monnot GC, Romero P, Speiser DE, Hebeisen M, Rufer N.

JCI Insight. 2017 Jul 20;2(14). pii: 92570. doi: 10.1172/jci.insight.92570. eCollection 2017 Jul 20.

3.

Rationale for immunological approaches to breast cancer therapy.

Monnot GC, Romero P.

Breast. 2018 Feb;37:187-195. doi: 10.1016/j.breast.2017.06.009. Epub 2017 Jun 17. Review.

PMID:
28629632
4.

MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.

Dudda JC, Salaun B, Ji Y, Palmer DC, Monnot GC, Merck E, Boudousquie C, Utzschneider DT, Escobar TM, Perret R, Muljo SA, Hebeisen M, Rufer N, Zehn D, Donda A, Restifo NP, Held W, Gattinoni L, Romero P.

Immunity. 2013 Apr 18;38(4):742-53. doi: 10.1016/j.immuni.2012.12.006.

5.

[Intoxication due to thionyl bromide].

Jouglard J, Airaudo CB, Grigorian G, Monnot G.

Eur J Toxicol. 1972 Jan-Feb;5(1):61-3. French. No abstract available.

PMID:
4647426
6.

[Acute poisoning by Mandrax. Evaluation of known cases at the Marseilles Poison Control Center (88 cases in 27 months)].

Jouglard J, Airaudo CB, Di Costanzo J, Grigorian G, Robaglia JL, Hebrard MJ, Monnot G.

Mars Med. 1972;109(9):565-7. French. No abstract available.

PMID:
4639561
7.

[Method of spectrographic analysis applicable to tissues and biological products].

MONNOT GA.

C R Hebd Seances Acad Sci. 1953 Apr 13;236(15):1492-4. Undetermined Language. No abstract available.

PMID:
13067250

Supplemental Content

Loading ...
Support Center